Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
Globenewswire· 2025-06-16 11:20
Award-Winning DEXA Technology™ Continues to Redefine Patient-Matched Spinal Care Please click to view image CARLSBAD, CALIFORNIA, June 16, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spinal implant technology, is proud to announce that its DEXA-C™ system has now been successfully used in more than 1,500 cervical spine procedures across the United States. This milestone underscores the ongoing adoption and trusted per ...
Tariff Talks Advance, What Taiwan Semiconductor Can Deliver
MarketBeat· 2025-06-16 11:19
Taiwan Semiconductor Manufacturing TodayTSMTaiwan Semiconductor Manufacturing$211.07 -4.36 (-2.02%) 52-Week Range$133.57▼$226.40Dividend Yield1.12%P/E Ratio29.98Price Target$217.00Add to WatchlistAny investor who has been exposed to the United States technology sector has learned the meaning of volatility over the past few quarters, especially as President Trump's trade tariffs start to significantly impact the sector’s future expectations and forecasts. However, not all are doomed for this space.Get TSM a ...
Future of Unilever's Ice Cream Business: A Planned Demerger in 2025
GlobeNewswire News Room· 2025-06-16 11:17
Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Unilever Group in Snacks (World)" company profile has been added to ResearchAndMarkets.com's offering.Unilever ranks sixth in overall snacks sales globally, but is the clear leader in the ice cream category, accounting for a fifth of retail value sales worldwide. However, 2024 is expected to be the last one in which Unilever's ice cream business was included in the group's overall earnings figures, with a demerger of this division planned by the company by the ...
DoubleDown Interactive: Insider Sale Doesn't Change The Fundamentals, I'm Doubling Down
Seeking Alpha· 2025-06-16 11:15
DoubleDown Interactive ( DDI ) recently took a tumble, falling 23.7% on June 12 after an insider sold shares at $8.50 each. Is it a Buy? I still think it is.I prefer to look for GARP (growth at a reasonable price) stocks but also look for opportunities everywhere else. I don't have a specified time horizon. I invest in a stock for as long as my thesis holds true, and I get out when the facts change. In addition, I've developed market-beating algorithms with Python that have helped me find attractive investm ...
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
Prnewswire· 2025-06-16 11:15
Updated Phase 2 data evaluating ZYNLONTA® as a monotherapy demonstrate overall response rate (ORR) of 85% and complete response (CR) rate of 69% CR maintained in 17 of 18 patients who achieved CR, with longest duration of CR of 27 months from start of treatmentZYNLONTA was generally well tolerated and safety was consistent with known profile LAUSANNE, Switzerland, June 16, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjug ...
Cooper-Standard: ReFi Back On The Table, Here's What It Means For The Stock
Seeking Alpha· 2025-06-16 11:14
Auto parts manufacturer Cooper-Standard ( CPS ) rocketed 44% on 2 May after announcing Q1 2025 results. The headline EPS figure of $0.09 was significantly better than the expected figure of -$1.14, though this arose because of a royalty payment from aI am a UK-based long-only investor with a strategy which revolves around finding companies which can be multi-baggers over a 5-10 year time horizon, though, as a great man once said, my favourite holding period is forever. I am looking for companies that have a ...
New Strong Buy Stocks for June 16th
ZACKS· 2025-06-16 11:06
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Flexsteel Industries, Inc. (FLXS) : This manufacturer of upholstered furniture has seen the Zacks Consensus Estimate for its current year earnings increasing 7.4% over the last 60 days.Rockwell Automation, Inc. (ROK) : This industrial automation and digital transformation solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.7% over the last 60 days.The E.W. Scripps Company (SSP) : This media ...
RYVYL Executes Strategic Actions Enhancing Its Business Plan and Files S-1 Registration Statement
Globenewswire· 2025-06-16 11:06
- Unveils Plans to Initiate Digital Asset Acquisition Strategy – - Enters LOI to Acquire Complementary Entity – - Realigns Corporate and North America Operations - SAN DIEGO, CA, June 16, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a leading innovator of payment transaction solutions leveraging electronic payment technology, has submitted a registration statement on Form S-1 with the Securities and Exchange Commission. The number of shares to be offered and the price range ...
Tariffs, EV And China Risks: Is Honda Stock Still Worth It?
Forbes· 2025-06-16 11:05
This photo shows signage at a car dealership for Japanese automaker Honda Motor along a street in ... More central Tokyo on May 13, 2025, ahead of the company's annual results announcement later in the day. (Photo by Richard A. Brooks / AFP) (Photo by RICHARD A. BROOKS/AFP via Getty Images)AFP via Getty ImagesJapan’s second-largest automaker, Honda Motor stock (NYSE: HMC), has predominantly fluctuated sideways this year, yielding approximately 2% since the beginning of January. Honda’s recent outcomes have ...
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
Globenewswire· 2025-06-16 11:05
NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rightsPhase 1 clinical trial ongoing for SIM0505 in China; U.S. Phase 1 clinical trial is expected to begin in the third quarter of 2025Initial Phase 1 clinical data is expected in the first half of 2026NextCure also gains rights to Simcere Zaiming’s proprietary linker and payload for use in an ADC directed to a NextCure novel target; Simcere Zaiming will have rights to greater China BELTSVILLE, Md. and SHANGH ...